This course has expired. View available courses.
Endocrinology
Case Studies in Diabetes: Escalating treatment with combination dulaglutide and insulin
This latest panel discussion reviews new opportunities in the management of type-2 diabetes brought about by recent changes to the RACGP/ADS guidelines and new PBS reimbursement criteria, particularly with regard to combination therapies. The video is framed around 2 case studies, which are discussed by the panellists. This program is supported by an independent educational grant […]
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
1
ACCREDITATION
RACGP CPD Program
EXPIRY DATE
2022-08-09
This latest panel discussion reviews new opportunities in the management of type-2 diabetes brought about by recent changes to the RACGP/ADS guidelines and new PBS reimbursement criteria, particularly with regard to combination therapies.
The video is framed around 2 case studies, which are discussed by the panellists.
This program is supported by an independent educational grant provided from Eli Lilly.
Faculty
Dr Anita Sharma, General Practitioner, Queensland.
Dr Ted Wu, Director of the Diabetes Centre, Royal Prince Alfred Hospital.
Prof Richard MacIsaac, Professor and Director of Endocrinology & Diabetes, St Vincent’s Health.
Learning objectives
This panel discussion is designed to enable participants to be better able to:
- Recognise the new PBS reimbursement criteria for use of GLP1-RAs in combination with insulin
- Identify ideal patient profiles for concomitant use of insulin with respect to achieving glycaemic control and CV benefit
- Discuss the clinical benefits of concomitant use of GLP1-RAs and insulin with patients
Accreditation
Members are able to claim CPD activity points for 1 points through 'Quick log' on their RACGP CPD Dashboard.